A recent study showed that CYLD phosphorylation is elevated in transformed cells and inhibition of this phosphorylation by IKK inhibitors triggers apoptosis, suggesting CYLD as a novel therapeutic target for adult T-cell leukemia [31]. The gene discussed is CYLD; the disease is adult T-cell leukemia/lymphoma.